Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploratory Study of ADR-002K for Heart Failure Patients With Ischemic Heart Disease Who Undergo Coronary Artery Bypass Surgery

NCT07192211 is registered in ClinicalTrials.gov with Rohto Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT07192211
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07192211 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploratory Study of ADR-002K for Heart Failure Patients With Ischemic Heart Disease Who Undergo Coronary Artery Bypass Surgery
Lead sponsor
Rohto Pharmaceutical Co., Ltd.
Phase
Phase 2
Overall status
Recruiting
Start date
April 28, 2026
Completion date
March 31, 2029
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic heart disease